Related references
Note: Only part of the references are listed.A Green Synthesis of Carbene-Metal-Amides (CMAs) and Carboline-Derived CMAs with Potent in vitro and ex vivo Anticancer Activity
Nikolaos Tzouras et al.
CHEMMEDCHEM (2022)
The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma
Zhao Cheng et al.
CLINICAL CANCER RESEARCH (2022)
Construction and Functional Evaluation of a Three-Dimensional Blood-Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells
Toshiki Kurosawa et al.
PHARMACEUTICAL RESEARCH (2022)
Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application
Alessandra Ciucci et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
Lana E. Kandalaft et al.
NATURE REVIEWS CANCER (2022)
Roadmap on nanomedicine
Paolo Decuzzi et al.
NANOTECHNOLOGY (2021)
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Carlotta Granchi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Fahriye Duzagac et al.
CANCERS (2021)
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2 NS) for Ovarian Cancer Therapy
Muhammad Adeel et al.
ACS OMEGA (2021)
Palladium(II)-η3-Allyl Complexes BearingN-TrifluoromethylN-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids
Thomas Scattolin et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
Silvia Vivarelli et al.
CANCERS (2020)
Flow-enhanced vascularization and maturation of kidney organoids in vitro
Kimberly A. Homan et al.
NATURE METHODS (2019)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Oded Kopper et al.
NATURE MEDICINE (2019)
High-resolution 3D imaging of fixed and cleared organoids
Johanna F. Dekkers et al.
NATURE PROTOCOLS (2019)
Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery
Claudia Beaurivage et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer
Concetta Russo Spena et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill et al.
CANCER DISCOVERY (2018)
Intestine-on-a-Chip Microfluidic Model for Efficient in Vitro Screening of Oral Chemotherapeutic Uptake
Kyall Pocock et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Intestine-on-a-Chip Microfluidic Model for Efficient in Vitro Screening of Oral Chemotherapeutic Uptake
Kyall Pocock et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform
Henriette L. Lanz et al.
BMC CANCER (2017)
Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device
Manuele Gori et al.
PLOS ONE (2016)
On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Mi Jang et al.
BIOMICROFLUIDICS (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin
Giuseppe Toffoli et al.
NANOMEDICINE (2015)
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
Shuo Wei et al.
NATURE MEDICINE (2015)
Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft
Gretchen Glaser et al.
PLOS ONE (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
Metabolic Characterization of Primary Rat Hepatocytes Cultivated in Parallel Microfluidic Biochips
Audrey Legendre et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Microfluidic heart on a chip for higher throughput pharmacological studies
Ashutosh Agarwal et al.
LAB ON A CHIP (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Controlled formation of heterotypic hepatic micro-organoids in anisotropic hydrogel microfibers for long-term preservation of liver-specific functions
Masumi Yamada et al.
BIOMATERIALS (2012)
Perturbation of Rb, p53, and Brca1 or Brca2 Cooperate in Inducing Metastatic Serous Epithelial Ovarian Cancer
Ludmila Szabova et al.
CANCER RESEARCH (2012)
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
Kathryn M. Kinross et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Brain slice on a chip: opportunities and challenges of applying microfluidic technology to intact tissues
Yu Huang et al.
LAB ON A CHIP (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
Alison M. Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
Amir A. Jazaeri et al.
NEOPLASIA (2011)
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Christopher G. Przybycin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
The Molecular Pathogenesis of Hereditary Ovarian Carcinoma
Barbara M. Norquist et al.
CANCER (2010)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Y. Lee et al.
JOURNAL OF PATHOLOGY (2007)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
JMJ Piek et al.
JOURNAL OF PATHOLOGY (2001)